Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 61Recruiting 30Unknown 18Terminated 13Active not recruiting 7Not yet recruiting 4Withdrawn 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 26Carcinoma, Renal Cell 10Melanoma 4Urinary Bladder Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Hyperplasia 1Penile Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nocturia 1Nephrolithiasis, Calcium Oxalate 1Multiple Myeloma 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Metastatic Castrate Resistant Prostate Cancer 1Mesothelioma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Liver Neoplasms × Genitourinary × Clear all
NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Envita Medical Center, Inc.

Phase 1 Suspended
24 enrolled
BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡